Skin lesion with a fatal neurologic outcome (Degos' disease)
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Degos' disease, or malignant atrophic papulosis, is a rare multisystem vasculopathy of unknown etiology. Kohlmeier [1] first reported it in 1941 as a form of thromboangiitis obliterans but in 1942 Degos et al. [2] described it as a distinct entity. The clinical hallmark of the disease is a cutaneous eruption on the trunk and extremities that is characterized as umbilicated papules with atrophic ``porcelain white'' centers that are painless but occasionally itchy. [3] The pathologic substrate of the disorder is progressive occlusion of middle- and small-sized arteries and veins, culminating in ischemic infarction of skin and viscera. [4] Inflammatory changes in the affected vessels are mild and infrequent. Gastrointestinal involvement is the most frequent systemic complication, with intestinal perforation being the most common cause of death. [5,6]
Nervous system involvement has included multiple cerebral infarcts, venous sinus thrombosis, subdural hematoma, and, less commonly, vascular cord lesions, myopathy, and neuropathy. [5,7-16] The neurologic manifestations of Degos' disease are rarely reported, and only anecdotally. We report the Mayo Clinic experience with the neurologic features of Degos' disease in a series of 15 patients.
Patients and methods.
The medical records of patients who were given the diagnosis of Degos' disease between 1954 and 1993 at Mayo Clinic Rochester and Mayo Clinic Scottsdale were retrospectively reviewed. Fifteen patients were included in the study who had the typical skin lesions of Degos' disease, which was confirmed by skin biopsy Figure 1 and Figure 2. One patient was excluded due to the absence of typical skin lesions. The duration of follow-up (onset of first symptom to last contact with the patient either during a clinic visit or via telephone/letter) ranged from 2 to 27 years (median, 13 years). Nine patients have survived and six patients have died. Autopsy reports of four of …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosisE. M. Wysokinska, W. E. Wysokinski, R. D. Brown et al.Neurology, February 19, 2008 -
Articles
Cerebral venous sinus thrombosisIncidence of venous thrombosis recurrence and survivalI. Gosk-Bierska, W. Wysokinski, R. D. Brown, Jr et al.Neurology, September 11, 2006 -
Resident and Fellow Section
Clinical Reasoning: A young woman with progressive headache and pancytopeniaErin C. Conrad, James E. Siegler, Joanna Mattis et al.Neurology, April 03, 2017 -
Articles
Is measurement of d-dimer useful in the diagnosis of cerebral venous thrombosis?P. H. Lalive, P. de Moerloose, K. Lovblad et al.Neurology, October 27, 2003